PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques
Abstract
Authors
S. Kaura G. Dranitsaris
S. Kaura G. Dranitsaris
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now